{"id":49536,"date":"2022-10-12T14:01:53","date_gmt":"2022-10-12T12:01:53","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/"},"modified":"2022-10-12T14:01:53","modified_gmt":"2022-10-12T12:01:53","slug":"palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/","title":{"rendered":"Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase"},"content":{"rendered":"<div>\n<p>WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fpalleonpharma.com%2F&amp;esheet=52942272&amp;newsitemid=20221012005153&amp;lan=en-US&amp;anchor=Palleon+Pharmaceuticals&amp;index=1&amp;md5=1c54753bf8f1a3ea9ccf1e8d077d9e6c\" rel=\"nofollow noopener\" shape=\"rect\">Palleon Pharmaceuticals<\/a>, a clinical-stage company pioneering glyco-immunology drug development to treat cancer and inflammatory diseases, today announced that the company will present at the Oppenheimer Healthcare Private Company Showcase: The Next Wave on Tuesday, October 18, 2022. Jim Broderick, M.D., Chief Executive Officer and founder of Palleon, will present a company overview at 11:45am PT and Palleon will host 1&#215;1 investor meetings, which can be requested through Oppenheimer.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221012005153\/en\/755022\/5\/Palleon.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221012005153\/en\/755022\/21\/Palleon.jpg\"><\/a><\/p>\n<p>\n<b>About Palleon Pharmaceuticals<br \/>\n<br \/><\/b>Palleon Pharmaceuticals, co-founded by Nobel laureate Carolyn Bertozzi, is a biotechnology company pioneering glyco-immunology drug development to transform the treatment of cancer and inflammatory diseases. The Company\u2019s proprietary platforms overcome technical barriers unique to glycobiology to enable drug discovery, patient selection, and indication prioritization to de-risk clinical development. The company\u2019s lead program in oncology, E-602, is a Phase 1\/2, first-in-class, glyco-immune checkpoint inhibitor which restores antitumor immunity by enzymatically degrading immunosuppressive sialoglycans on hypersialylated tumors and immune cells. Palleon has a rich pipeline of additional drug candidates including several advancing toward IND-enabling studies.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media<\/b><br \/>Thomas Stephenson<br \/>\n<br \/>Ten Bridge Communications<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;t&#111;&#x3a;&#116;&#x68;o&#x6d;a&#115;&#x40;&#116;&#x65;n&#x62;&#x72;&#105;&#x64;g&#x65;c&#111;&#x6d;&#109;&#x75;n&#x69;c&#97;&#x74;&#105;&#x6f;n&#115;&#x2e;&#99;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#116;&#x68;&#111;&#x6d;&#97;&#x73;&#64;&#x74;e&#110;&#x62;&#114;&#x69;&#100;&#x67;e&#x63;o&#109;&#x6d;&#117;&#x6e;&#105;&#x63;&#97;&#x74;i&#x6f;n&#115;&#x2e;&#99;&#x6f;&#109;<\/a><br \/>(857) 244-0246\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;Palleon Pharmaceuticals, a clinical-stage company pioneering glyco-immunology drug development to treat cancer and inflammatory diseases, today announced that the company will present at the Oppenheimer Healthcare Private Company Showcase: The Next Wave on Tuesday, October 18, 2022. Jim Broderick, M.D., Chief Executive Officer and founder of Palleon, will present a company overview at &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49536","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;Palleon Pharmaceuticals, a clinical-stage company pioneering glyco-immunology drug development to treat cancer and inflammatory diseases, today announced that the company will present at the Oppenheimer Healthcare Private Company Showcase: The Next Wave on Tuesday, October 18, 2022. Jim Broderick, M.D., Chief Executive Officer and founder of Palleon, will present a company overview at ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-12T12:01:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221012005153\/en\/755022\/21\/Palleon.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase\",\"datePublished\":\"2022-10-12T12:01:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\\\/\"},\"wordCount\":191,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221012005153\\\/en\\\/755022\\\/21\\\/Palleon.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\\\/\",\"name\":\"Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221012005153\\\/en\\\/755022\\\/21\\\/Palleon.jpg\",\"datePublished\":\"2022-10-12T12:01:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221012005153\\\/en\\\/755022\\\/21\\\/Palleon.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221012005153\\\/en\\\/755022\\\/21\\\/Palleon.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/","og_locale":"en_US","og_type":"article","og_title":"Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase - Pharma Trend","og_description":"WALTHAM, Mass.&#8211;(BUSINESS WIRE)&#8211;Palleon Pharmaceuticals, a clinical-stage company pioneering glyco-immunology drug development to treat cancer and inflammatory diseases, today announced that the company will present at the Oppenheimer Healthcare Private Company Showcase: The Next Wave on Tuesday, October 18, 2022. Jim Broderick, M.D., Chief Executive Officer and founder of Palleon, will present a company overview at ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-12T12:01:53+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221012005153\/en\/755022\/21\/Palleon.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase","datePublished":"2022-10-12T12:01:53+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/"},"wordCount":191,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221012005153\/en\/755022\/21\/Palleon.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/","url":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/","name":"Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221012005153\/en\/755022\/21\/Palleon.jpg","datePublished":"2022-10-12T12:01:53+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221012005153\/en\/755022\/21\/Palleon.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221012005153\/en\/755022\/21\/Palleon.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/palleon-pharmaceuticals-to-present-at-the-oppenheimer-healthcare-private-company-showcase\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Palleon Pharmaceuticals to Present at the Oppenheimer Healthcare Private Company Showcase"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49536","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49536"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49536\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49536"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49536"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}